Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul:128:104425.
doi: 10.1016/j.jcv.2020.104425. Epub 2020 May 7.

Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes

Affiliations

Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes

Hui Peng et al. J Clin Virol. 2020 Jul.

Abstract

Background: At present, coronavirus disease 2019 (COVID-19) has spread in many countries. We conducted this study to help pediatricians understand the conditions of COVID-19 in children.

Methods: We retrospectively summarized the characteristics, treatment and outcomes of pediatric cases in Wuhan Children's Hospital which was the only designated hospital for children with COVID-19 in Hubei Province. A Cox proportional hazards regression analysis was used to evaluate factors associated with clinical outcomes.

Results: As of February 29, 75 children had been discharged, of which only one was has severe pneumonia and one was critical cases. Children younger than 2 years were more susceptible to COVID-19. All patients have received interferon-α nebulization, and eight cases including the severe and critical cases were co-administrated ribavirin. Five patients with mild pneumonia were given arbidol. Twenty-three patients were given traditional Chinese medicine (TCM). The average length of stay (LOS) and the time of SARS-CoV-2 clearance were 10.57 and 6.39 days, respectively. None of the factors was associated with LOS or time of SARS-CoV-2 clearance.

Conclusions: The severity of COVID-19 in pediatric cases were milder than adults. The efficacy of the antiviral therapy in children with COVID-19 remains to be evaluated.

Keywords: Characteristics; Coronavirus disease 2019; Outcomes; Pediatric; Treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest All authors certify no potential conflicts of interest.

Figures

Fig. 1
Fig. 1
Age distribution of the pediatric patients with COVID-19 (n = 75).
Fig. 2
Fig. 2
The length of hospital stay of the pediatric patients with COVID-19 (n = 75).
Fig. 3
Fig. 3
The duration of SARS-CoV-2 RNA clearance in the pediatric patients with COVID-19 (n = 75).

References

    1. Cai J., Xu J., Lin D. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin. Infect. Dis. 2020 Online ahead of print. - PMC - PubMed
    1. Pediatric Branch of Hubei Medical Association, Pediatric Branch of Wuhan Medical Association, Pediatric Medical Quality Control Center of Hubei [Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)] Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(2):96–99. (in Chinese) - PMC - PubMed
    1. Chinese Medical Association Society of Pediatrics, Chinese Journal of Pediatrics Editorial Board [Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)] Zhonghua Er Ke Za Zhi. 2020;58(0):E004. (in Chinese) - PubMed
    1. Shen K., Yang Y., Wang T. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J. Pediatr. 2020;7:1–9. - PMC - PubMed
    1. Chen Z.-M., Fu J.-F., Shu Q. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J. Pediatr. 2020;5:1–7. - PMC - PubMed

MeSH terms